Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

CGS 19755 (Selfotel): A Novel Neuroprotective Agent Against CNS Injury.

Pérez-Pinzón MA, Steinberg GK.

CNS Drug Rev. 1996 Sep 1;2(3):257-268.

2.

Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats.

Miyabe M, Kirsch JR, Nishikawa T, Koehler RC, Traystman RJ.

Crit Care Med. 1997 Jun;25(6):1037-43.

PMID:
9201058
3.

N-methyl-D-aspartate antagonists for stroke and head trauma.

Wood PL, Hawkinson JE.

Expert Opin Investig Drugs. 1997 Apr;6(4):389-97.

PMID:
15989606
4.

Correlation of CGS 19755 neuroprotection against in vitro excitotoxicity and focal cerebral ischemia.

Pérez-Pinzón MA, Maier CM, Yoon EJ, Sun GH, Giffard RG, Steinberg GK.

J Cereb Blood Flow Metab. 1995 Sep;15(5):865-76.

PMID:
7673380
5.

Efficacy of competitive vs noncompetitive blockade of the NMDA channel following traumatic brain injury.

Golding EM, Vink R.

Mol Chem Neuropathol. 1995 Feb-Apr;24(2-3):137-50.

PMID:
7632318
6.

Dose escalation safety and tolerance study of the competitive NMDA antagonist selfotel (CGS 19755) in neurosurgery patients.

Yenari MA, Bell TE, Kotake AN, Powell M, Steinberg GK.

Clin Neuropharmacol. 1998 Jan-Feb;21(1):28-34.

PMID:
9579282
7.
9.

Protective use of N-methyl-D-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity.

Cho Y, Ueda T, Mori A, Shimizu H, Haga Y, Yozu R.

J Vasc Surg. 2005 Oct;42(4):765-71.

10.

Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?

Buchan AM.

Cerebrovasc Brain Metab Rev. 1990 Spring;2(1):1-26. Review.

PMID:
2144995
11.

Cerestat and other NMDA antagonists in ischemic stroke.

Lees KR.

Neurology. 1997 Nov;49(5 Suppl 4):S66-9. Review.

PMID:
9371155
12.

Competitive NMDA receptor antagonists and spinal-cord ischemia.

Follis F, Blisard K, Varvitsiotis PS, Pett SB Jr, Temes T, Wernly JA.

J Invest Surg. 2000 Mar-Apr;13(2):117-21; discussion 123-4.

PMID:
10801049
13.
14.

Clinical experience with excitatory amino acid antagonist drugs.

Muir KW, Lees KR.

Stroke. 1995 Mar;26(3):503-13. Review.

15.

Focal ischemia enhances the adverse effect potential of N-methyl-D-aspartate receptor antagonists in rats.

Löscher W, Wlaź P, Szabo L.

Neurosci Lett. 1998 Jan 2;240(1):33-6.

PMID:
9488168
16.

Glutamate AMPA receptor antagonist treatment for ischaemic stroke.

Akins PT, Atkinson RP.

Curr Med Res Opin. 2002;18 Suppl 2:s9-13.

PMID:
12365832
17.
20.

Supplemental Content

Support Center